|
Almela P, Atucha NM, Milanés MV, Laorden ML. Cross-talk between protein kinase A and mitogen-activated protein kinases signalling in the adaptive changes observed during morphine withdrawal in the heart. J Pharmacol Exp Ther. 2009 Sep;330(3):771-82. doi: 10.1124/jpet.109.154583. Epub 2009 Jun 30. PubMed PMID: 19567779.
AÑO: 2009; IF: 4.03
|
19567779
|
Almela P, Milanés M, Laorden M. The PKs PKA and ERK 1/2 are involved in phosphorylation of TH at Serine 40 and 31 during morphine withdrawal in rat hearts. Br J Pharmacol. 2008 Sep;155(1):73-83. doi: 10.1038/bjp.2008.224. Epub 2008 Jun 9. PubMed PMID: 18536752; PubMed Central PMCID: PMC2527841.
AÑO: 2008; IF: 8.739
|
|
Almela P, Milanés MV, Laorden ML. Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal. Br J Pharmacol. 2007 Jul;151(6):787-97. Epub 2007 Jun 4. PubMed PMID: 17549049; PubMed Central PMCID: PMC2014132.
AÑO: 2007; IF: 8.739
|
|
Almela P, Cerezo M, González-Cuello A, Milanés MV, Laorden ML. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal. Naunyn Schmiedebergs Arch Pharmacol. 2007 Jan;374(4):293-303. Epub 2006 Nov 25. PubMed PMID: 17216288.
AÑO: 2007; IF: 2.161
|
|
Almela P, Cerezo M, Milanés MV, Laorden ML. Role of PKC in regulation of Fos and TH expression after naloxone induced morphine withdrawal in the heart. Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):374-82. Epub 2006 Feb 11. PubMed PMID: 16474935.
AÑO: 2006; IF: 2.779
|